AI in drug discovery

News

Xaira Therapeutics co-founder Dr David Baker

Enter Xaira, with $1bn for its AI in drug discovery platform

Any new company wanting to make waves in applying artificial intelligence to drug discovery will need deep pockets and a top-tier science and management team – and startup

News

Shakeup at BenevolentAI continues with job, programme cuts

BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third

Digital

AI in Drug Discovery: Day Two

Back in the picturesque West End of London, even a sudden, torrential downpour could not dampen the spirits on 12th March as speakers and attendees returned once more to the Hilton Hotel in

News

Merck taps Caris’ AI expertise in ADC-focused alliance

Germany’s Merck KGaA has partnered with techbio company Caris Discovery in a $1.4 billion alliance that will apply artificial intelligence to the design of antibody-drug c

Digital

AI in Drug Discovery: Day One

There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector.

Digital

Digital tools must be used in pharma manufacturing to keep p...

The pace of change in drug discovery and clinical development has been unmatched in recent years, with technologies such as AI accelerating these processes.

Enter Xaira, with $1bn for its AI in drug discovery platform

Shakeup at BenevolentAI continues with job, programme cuts

AI in Drug Discovery: Day Two

Merck taps Caris’ AI expertise in ADC-focused alliance

AI in Drug Discovery: Day One

Digital tools must be used in pharma manufacturing to keep p...

Protego's $130m for amyloidosis drug, and other financings

How to meet your physicians where they are online

AI in drug discovery

Editor's Picks